(Q34563686)

English

Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Overview of rationale and clinical trials with signal transduction inhibitors in lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Carlos L Arteaga

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Fadlo Khuri

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Geoffrey Krystal

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Said Sebti

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Seminars in Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

15-26

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

0 references

Identifiers

10.1053/SONC.2002.31524

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34563686&oldid=2044956919"